José Martínez-González Selected Research

Connective Tissue Growth Factor

3/2016

The lysyl oxidase inhibitor (β-aminopropionitrile) reduces leptin profibrotic effects and ameliorates cardiovascular remodeling in diet-induced obesity in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

José Martínez-González Research Topics

Disease

22	Atherosclerosis 02/2024 - 01/2003
20	Inflammation (Inflammations) 11/2023 - 01/2007
10	Abdominal Aortic Aneurysm 12/2023 - 12/2013
9	Atherosclerotic Plaque (Atheroma) 02/2024 - 09/2002
8	Thrombosis (Thrombus) 10/2020 - 03/2003
6	Aneurysm (Aneurysms) 12/2023 - 01/2016
6	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 07/2008
5	Heart Failure 11/2022 - 01/2013
5	Vascular Remodeling 01/2021 - 03/2011
5	Hypoxia (Hypoxemia) 09/2016 - 11/2009
4	Cardiomegaly (Heart Hypertrophy) 11/2023 - 03/2016
4	Rupture 01/2021 - 01/2008
4	Fibrosis (Cirrhosis) 01/2020 - 01/2013
4	Stroke (Strokes) 05/2018 - 01/2007
4	Myocardial Infarction 05/2018 - 03/2006
3	Hypercholesterolemia 02/2024 - 09/2002
3	Obesity 11/2019 - 06/2015
3	Body Weight (Weight, Body) 11/2019 - 06/2015
3	Heart Diseases (Heart Disease) 09/2015 - 11/2011
3	Neoplasms (Cancer) 05/2010 - 02/2008
2	Vascular Diseases (Vascular Disease) 01/2023 - 08/2009
2	Neointima 05/2013 - 05/2013
2	Venous Thromboembolism 05/2010 - 07/2008
2	Necrosis 08/2009 - 01/2008
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 02/2008 - 06/2007
2	Wounds and Injuries (Trauma) 02/2006 - 01/2003
1	Aortic Rupture 12/2023
1	Aortic Valve Disease 11/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2023
1	Infarction (Infarctions) 12/2021
1	Reperfusion Injury 12/2021
1	Myocardial Ischemia (Ischemic Heart Diseases) 12/2021
1	Hypertension (High Blood Pressure) 10/2019
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2019
1	Chronic Disease (Chronic Diseases) 01/2019
1	Progeria (Hutchinson Gilford Syndrome) 05/2018
1	Vascular Calcification 05/2018
1	Premature Aging 05/2018
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018

Drug/Important Bio-Agent (IBA)

10	Messenger RNA (mRNA)IBA 08/2022 - 11/2004
9	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 02/2024 - 07/2008
8	Apolipoproteins E (ApoE)IBA 02/2024 - 12/2013
7	EnzymesIBA 02/2024 - 01/2007
6	LipidsIBA 02/2024 - 01/2008
6	Proteins (Proteins, Gene)FDA Link 05/2018 - 03/2003
5	CollagenIBA 11/2023 - 01/2013
5	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 08/2022 - 09/2016
5	Transcription Factors (Transcription Factor)IBA 10/2021 - 01/2003
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 03/2006
4	oxidized low density lipoproteinIBA 08/2022 - 09/2002
4	CytokinesIBA 01/2021 - 09/2011
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 04/2021 - 01/2007
3	Angiotensin IIIBA 01/2021 - 01/2017
3	Thrombin FDA Link 06/2012 - 02/2008
2	RolipramIBA 12/2023 - 03/2021
2	CholesterolIBA 09/2023 - 11/2016
2	ApolipoproteinsIBA 01/2023 - 11/2011
2	Superoxides (Superoxide)IBA 12/2021 - 03/2016
2	ElementsIBA 04/2021 - 02/2008
2	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 01/2018
2	AminopropionitrileIBA 03/2016 - 06/2015
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2016 - 01/2016
2	Histone Deacetylase InhibitorsIBA 01/2016 - 01/2016
2	ProstaglandinsIBA 12/2013 - 04/2011
2	bemiparinIBA 05/2010 - 07/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2009 - 02/2006
2	Simvastatin (Zocor)FDA LinkGeneric 08/2009 - 08/2005
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 02/2008 - 06/2007
2	C-Reactive ProteinIBA 02/2008 - 06/2007
2	Hemostatics (Antihemorrhagics)IBA 02/2008 - 06/2007
2	DNA (Deoxyribonucleic Acid)IBA 02/2006 - 01/2003
2	Antisense OligonucleotidesIBA 02/2006 - 01/2003
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 11/2023
1	MineralsIBA 11/2023
1	CateninsIBA 05/2023
1	4-phenylbutyric acid (Buphenyl)FDA Link 01/2023
1	Metformin (Glucophage)FDA LinkGeneric 01/2023
1	Antihypertensive Agents (Antihypertensives)IBA 01/2023
1	ursodoxicoltaurineIBA 01/2023
1	Doxycycline (Periostat)FDA LinkGeneric 01/2023
1	CarbohydratesIBA 07/2022
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2021
1	ChemokinesIBA 01/2021
1	Member 3 Group A Nuclear Receptor Subfamily 4IBA 01/2021
1	ElastinIBA 01/2021
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 01/2020
1	mitoquinoneIBA 11/2019
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 11/2019
1	AntioxidantsIBA 11/2019
1	Pattern Recognition ReceptorsIBA 01/2019
1	NucleotidesIBA 01/2019
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2019
1	prelamin AIBA 05/2018
1	acetyl-LDLIBA 01/2018
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2018

Therapy/Procedure

4	Therapeutics 01/2023 - 06/2007
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2016
2	Renal Dialysis (Hemodialysis) 05/2010 - 07/2008
1	Patient Readmission 11/2022